Compare PAI & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PAI | INO |
|---|---|---|
| Founded | 1973 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 118.3M | 116.1M |
| IPO Year | N/A | 1998 |
| Metric | PAI | INO |
|---|---|---|
| Price | $12.55 | $1.52 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 25.0K | ★ 2.0M |
| Earning Date | 01-01-0001 | 11-10-2025 |
| Dividend Yield | ★ 4.78% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $182,337.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $23,060.18 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.59 | $1.30 |
| 52 Week High | $12.63 | $2.98 |
| Indicator | PAI | INO |
|---|---|---|
| Relative Strength Index (RSI) | 55.42 | 35.49 |
| Support Level | $12.47 | $1.50 |
| Resistance Level | $12.68 | $1.70 |
| Average True Range (ATR) | 0.08 | 0.11 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 40.91 | 8.89 |
Western Asset Investment Grade Income Fund Inc is a closed-end diversified investment company. The company designed as a long-term investment and not as a trading vehicle. The fund seeks a high level of current income, consistent with prudent investment risk, through investment in a diversified portfolio of debt securities. Its portfolio is invested in securities which may be convertible into or exchangeable for, or carry warrants to purchase, common stock or other equity interests; and preferred stock.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.